Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno-occlusive disease after bone marrow transplantation.

作者信息

Ohwada Chikako, Takeuchi Masahiro, Kawaguchi Takeharu, Tsukamoto Shokichi, Sakai Shio, Takeda Yusuke, Abe Daijiro, Sakaida Emiko, Shimizu Naomi, Yokote Koutaro, Iseki Tohru, Nakaseko Chiaki

机构信息

Department of Hematology, Chiba University Hospital, Chiba, Japan.

出版信息

Am J Hematol. 2011 Oct;86(10):886-8. doi: 10.1002/ajh.22137. Epub 2011 Aug 4.

DOI:10.1002/ajh.22137

PMID:21818767

Abstract

摘要

相似文献

Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno-occlusive disease after bone marrow transplantation.

Am J Hematol. 2011 Oct;86(10):886-8. doi: 10.1002/ajh.22137. Epub 2011 Aug 4.

Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Bone Marrow Transplant. 2010 Apr;45(4):783-5. doi: 10.1038/bmt.2009.217. Epub 2009 Aug 31.

No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.重组人组织型纤溶酶原激活剂治疗异基因骨髓移植后肝静脉闭塞病无有益作用，但有严重副作用。

Transplant Proc. 1995 Dec;27(6):3535.

Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.前列腺素E1治疗骨髓移植后肝静脉闭塞病

Bone Marrow Transplant. 1991;7 Suppl 2:53.

Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT.

Bone Marrow Transplant. 2012 Mar;47(3):463-4. doi: 10.1038/bmt.2011.103. Epub 2011 May 9.

Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.

Bone Marrow Transplant. 2016 Nov;51(11):1543-1545. doi: 10.1038/bmt.2016.179. Epub 2016 Jul 4.

Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).重组组织型纤溶酶原激活剂（rt-PA）成功治疗异基因骨髓移植术后并发的肝静脉闭塞病。

Bone Marrow Transplant. 1990 Jun;5(6):439-41.

[Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].重组人组织型纤溶酶原激活剂（rh-tPA）治疗骨髓移植后肝静脉闭塞病

Rinsho Ketsueki. 2000 Feb;41(2):103-8.

Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) Centers.儿童肝静脉闭塞病（VOD）的管理：意大利儿科血液肿瘤协会-骨髓移植组6个AIEOP-BMT中心的回顾性分析

Bone Marrow Transplant. 1996 Nov;18 Suppl 2:157-9.

[Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].经皮肝内门体分流术治疗骨髓移植后肝静脉闭塞病

Gastroenterol Hepatol. 2000 Apr;23(4):177-80.

引用本文的文献

Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.血液恶性肿瘤弥漫性血管内凝血的诊断与治疗进展。

Int J Hematol. 2021 Jan;113(1):34-44. doi: 10.1007/s12185-020-02992-w. Epub 2020 Sep 9.

Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.弥散性血管内凝血及其他危急情况下的血栓调节蛋白——一种具有治疗潜力的多功能抗凝蛋白。

Crit Care. 2019 Aug 15;23(1):280. doi: 10.1186/s13054-019-2552-0.

Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.可溶性血栓调节蛋白减轻肝窦阻塞综合征中的内皮细胞损伤。

In Vivo. 2018 Nov-Dec;32(6):1409-1417. doi: 10.21873/invivo.11393.

Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain.血栓调节蛋白第五个表皮生长因子样功能区 C 环可保持其细胞保护和促血管生成功能。

Haematologica. 2018 Oct;103(10):1730-1740. doi: 10.3324/haematol.2017.184481. Epub 2018 Jun 14.

Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies.依库珠单抗与重组人可溶性血栓调节蛋白联合治疗对一名因抗H因子自身抗体导致非典型溶血尿毒综合征的7岁女童的疗效。

CEN Case Rep. 2014 May;3(1):110-117. doi: 10.1007/s13730-013-0097-7. Epub 2013 Sep 12.

Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.

Bone Marrow Transplant. 2017 Jul;52(7):1068-1070. doi: 10.1038/bmt.2017.65. Epub 2017 Apr 3.

Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.

Bone Marrow Transplant. 2016 Nov;51(11):1543-1545. doi: 10.1038/bmt.2016.179. Epub 2016 Jul 4.

Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.异基因干细胞移植后早期凝血障碍是与移植相关死亡率的一个强有力的预后因素，用重组人血栓调节蛋白进行干预可改善结局：一项单中心经验。

Int J Hematol. 2013 Nov;98(5):533-42. doi: 10.1007/s12185-013-1443-4. Epub 2013 Oct 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验